DE69724647D1 - Acyclovirhaltige antiherpesarzneistift zur topischen anwendung - Google Patents

Acyclovirhaltige antiherpesarzneistift zur topischen anwendung

Info

Publication number
DE69724647D1
DE69724647D1 DE69724647T DE69724647T DE69724647D1 DE 69724647 D1 DE69724647 D1 DE 69724647D1 DE 69724647 T DE69724647 T DE 69724647T DE 69724647 T DE69724647 T DE 69724647T DE 69724647 D1 DE69724647 D1 DE 69724647D1
Authority
DE
Germany
Prior art keywords
acyclovir
topical use
containing anti
thermal tip
stick
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69724647T
Other languages
English (en)
Inventor
Giancarlo Santus
Roberto Golzi
Antonio Garavaglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Application granted granted Critical
Publication of DE69724647D1 publication Critical patent/DE69724647D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69724647T 1996-10-31 1997-10-31 Acyclovirhaltige antiherpesarzneistift zur topischen anwendung Expired - Lifetime DE69724647D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002258A IT1287114B1 (it) 1996-10-31 1996-10-31 Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
PCT/EP1997/006022 WO1998018472A1 (en) 1996-10-31 1997-10-31 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators

Publications (1)

Publication Number Publication Date
DE69724647D1 true DE69724647D1 (de) 2003-10-09

Family

ID=11375126

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724647T Expired - Lifetime DE69724647D1 (de) 1996-10-31 1997-10-31 Acyclovirhaltige antiherpesarzneistift zur topischen anwendung

Country Status (13)

Country Link
EP (1) EP0948332B1 (de)
JP (1) JP2001503404A (de)
KR (1) KR20000052678A (de)
CN (1) CN1235547A (de)
AT (1) ATE248597T1 (de)
AU (1) AU724741B2 (de)
BR (1) BR9712610A (de)
CA (1) CA2270254A1 (de)
DE (1) DE69724647D1 (de)
IT (1) IT1287114B1 (de)
NO (1) NO991910L (de)
NZ (1) NZ335685A (de)
WO (1) WO1998018472A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU3853800A (en) * 1999-01-11 2000-08-01 Ahmet Degirmenci Pharmaceutical forms and methods for penetration continuity
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20040091539A1 (en) * 2002-11-13 2004-05-13 Ake Lindahl Dermastick thickened ointment
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
KR20070104912A (ko) * 2005-02-17 2007-10-29 센주 세이야꾸 가부시키가이샤 안과용 고형 외용약제
KR20080032189A (ko) * 2005-08-17 2008-04-14 찰스 씨. 타드록 식욕 억제를 위한 전달 시스템
JP4013076B2 (ja) * 2005-09-30 2007-11-28 小林製薬株式会社 固形状の外用医薬組成物
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
DE102007061897A1 (de) * 2007-12-20 2009-06-25 Matthias Dr. Hempel Paraffinfreier Lippenpflegestift
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039638A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
CN103751100B (zh) * 2013-11-28 2015-09-16 郑州韩都药业集团有限公司 一种阿昔洛韦乳膏
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB201819418D0 (en) * 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
MX2021015247A (es) * 2019-06-14 2022-02-11 Propella Therapeutics Inc Formulaciones topicas de aciclovir y usos de las mismas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections

Also Published As

Publication number Publication date
CN1235547A (zh) 1999-11-17
AU6907898A (en) 1998-05-22
JP2001503404A (ja) 2001-03-13
ATE248597T1 (de) 2003-09-15
ITMI962258A1 (it) 1998-05-01
IT1287114B1 (it) 1998-08-04
NZ335685A (en) 2000-03-27
WO1998018472A1 (en) 1998-05-07
CA2270254A1 (en) 1998-05-07
AU724741B2 (en) 2000-09-28
KR20000052678A (ko) 2000-08-25
BR9712610A (pt) 1999-12-21
NO991910D0 (no) 1999-04-21
NO991910L (no) 1999-06-21
EP0948332B1 (de) 2003-09-03
EP0948332A1 (de) 1999-10-13

Similar Documents

Publication Publication Date Title
DE69724647D1 (de) Acyclovirhaltige antiherpesarzneistift zur topischen anwendung
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
PT671161E (pt) Ectoina e derivados de ectoina como distribuidor de humidade em produtos cosmeticos
WO1998010767A3 (en) Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
CA2404810A1 (en) Topical composition having undifferentiated plant seed cells and method for using same
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
EP1259240B8 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
BR9403783A (pt) Uso de uma composição cosmética
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
AU4775099A (en) Trichological lotion for topical use
IT1270602B (it) Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
IL103101A (en) Topical composition for rejuvenating skin
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ATE173627T1 (de) Medizinische zusammensetzung
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
KR970009581B1 (en) Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
GR1001511B (el) Στεροειδείς συν?έσεις.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
ES2176786T3 (es) Uso de extractos de ginkgo biloba para la preparacion de composicionesfarmaceuticas.
EP1055413A3 (de) Wirkstoffkombinationen aus sulfonierten UV-Filtersubstanzen und Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden sowie kosmetische Zubereitungen, solche Wirkstoffkombinationen enthaltend

Legal Events

Date Code Title Description
8332 No legal effect for de